DopFone is a mobile app that turns a smartphone speaker into a Doppler-like sensor so pregnant people can monitor a fetal heartbeat at home between checkups. The project was developed at Georgia Tech after Alex Adams and his wife experienced two miscarriages; Adams says the idea is about "filling the gaps between checkups." Poojita Garg joined the work while completing her master’s degree and is now pursuing a PhD at the University of Washington.
Garg tested DopFone on 23 patients and reported a plus–minus of 4.9 beats per minute, which is within the clinical standard range of eight beats per minute for reliable fetal heart rate measurement. Adams says the app measured within two beats per minute in most cases, with an error rate of less than 1%.
Researchers say the app could give more consistent heart rate data outside clinics and may help people in areas with limited health care. They caution it may increase anxiety for some users and say it should be recommended by a doctor, not replace clinic care. The research appears in Proceedings of the ACM. Source: Georgia Tech.
Difficult words
- miscarriage — loss of a pregnancy before birthmiscarriages
- checkup — a routine medical appointment to check healthcheckups
- sensor — a device that detects or measures something
- clinical — related to medical treatment or hospitals
- error rate — the frequency of mistakes in a measurement
- anxiety — a feeling of worry or nervousness
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you use an app like DopFone to check a fetal heartbeat at home? Why or why not?
- How could tools like this help people who live far from clinics or have limited health care access?
- What problems might happen if people rely on an app instead of visiting a doctor?
Related articles
Wheat fiber protects mice from intestinal inflammation
Two research papers report that adding wheat fiber to the diet protects mice from intestinal inflammation. Gut bacteria release polyphenols from the fiber that reduce inflammation, and authors suggest whole-grain foods may lower IBD risk.
Emory study: 2023–24 COVID vaccine gives lasting antibodies
Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.
PAHO issues first guide for tungiasis treatment
PAHO has published the first evidence-based guide to treat tungiasis, recommending low-viscosity dimethicone and warning against unsafe manual removal. The disease affects millions in Latin America, the Caribbean and Sub-Saharan Africa.